Primary hyperoxaluria: the pediatric nephrologist's point of view
Related Experiment Video
Updated: Sep 22, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Efrat Ben-Shalom1, Sander F Garrelfs2, Jaap W Groothoff2
1Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.
Insights
Primary hyperoxaluria in children presents diverse symptoms, from kidney issues to systemic oxalosis. Treatment involves managing kidney function, dialysis, transplantation, and exploring new RNA interference therapies.
Area of Science:
- Pediatric Nephrology
- Metabolic Disorders
- Genetics
Background:
- Primary hyperoxaluria (PH) is a rare genetic disorder.
- It leads to oxalate deposition in kidneys and other organs.
- Pediatric PH can cause severe kidney damage and systemic oxalosis.
Purpose of the Study:
- To review the clinical manifestations of pediatric primary hyperoxaluria.
- To discuss current and emerging treatment strategies.
- To address ethical considerations in managing this condition.
Main Methods:
- Literature review of primary hyperoxaluria in children.
- Analysis of clinical presentations and outcomes.
- Evaluation of treatment modalities including dialysis and transplantation.
Main Results:
- Clinical spectrum ranges from nephrocalcinosis to end-stage kidney failure.
- Systemic oxalosis is a severe complication.
- Liver or combined liver/kidney transplantation is the definitive treatment for PH type 1.
Conclusions:
- Early diagnosis and management are crucial.
- Novel treatments like RNA interference show promise.
- Multidisciplinary care and ethical considerations are vital for pediatric PH patients.
Abstract:
The clinical presentation of primary hyperoxaluria in children ranges from mildly symptomatic nephrocalcinosis to very early onset end-stage kidney failure with systemic oxalosis, a devastating complication. We review the various manifestations of pediatric hyperoxaluria, treatment options for children with preserved kidney function and appropriate dialysis regimens. Liver or combined liver/kidney transplantation is currently the only definitive treatment for primary hyperoxaluria type 1, but novel RNA interference treatments offer hope for the future. Finally, we address the medical and ethical dilemmas facing pediatricians treating children with hyperoxaluria.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Nephrotic Syndrome I : Introduction
Inborn Errors of Metabolism